(VIANEWS) – The NASDAQ ended the session with Catalyst Pharmaceuticals rising 10.47% to $6.12 on Wednesday, following the last session’s downward trend. NASDAQ Composite rose 0.47% to $14,501.91, after two sequential sessions in a row of losses, on what was a somewhat up trend exchanging session today.


Today’s last reported volume for Catalyst Pharmaceuticals is 1734740, 109.21% above its average volume of 829160.

Catalyst Pharmaceuticals’s last close was $5.21, 16.51% below its 52-week high of $6.24.

Catalyst Pharmaceuticals’s Sales

Catalyst Pharmaceuticals’s sales growth is 18% for the ongoing quarter and 15.6% for the next.

Catalyst Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth grew by 22.8%, now sitting on 126.9M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Catalyst Pharmaceuticals’s stock is considered to be overbought (>=80).

Catalyst Pharmaceuticals’s Stock Yearly Top and Bottom Value

Catalyst Pharmaceuticals’s stock is valued at $6.12 at 17:06 EST, below its 52-week high of $6.24 and way above its 52-week low of $2.88.

Catalyst Pharmaceuticals’s Moving Average

Catalyst Pharmaceuticals’s worth is way above its 50-day moving average of $5.26 and way above its 200-day moving average of $5.27.

More news about Catalyst Pharmaceuticals (CPRX).


Please enter your comment!
Please enter your name here